Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
Clinical trial NCT01951625 · COMPLETED
Trial details
- NCT number
- NCT01951625
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-29
- Primary completion
- 2015-05-14
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.